Antenatal and Postnatal Diagnosis of Coxsackie B4 Infection: Case Series

Abstract

Enteroviruses are a common cause of neonatal infection. In particular, Coxsackie B viruses are often associated with severe, fatal disease. The antenatal diagnosis of Coxsackie B viral infections is uncommon. We present a unique case of Coxsackie B4 virus ventriculitis and myocarditis causing fetal hydrops at 22 weeks gestation. Transmission was inferred by viral isolation from the amniotic fluid and by placental pathology. We also describe two additional cases of fatal neonatal Coxsackie B4 infection complicated by myocarditis and encephalitis with cerebral necrosis in a 4-day-old female and by myocarditis, spinal leptomeningitis, and hepatitis in a 4-day-old male. Transplacental acquisition of infection carries a poor prognosis. We propose that Coxsackie B virus should be considered in the investigation of nonimmune hydrops, particularly in the presence of cardiac dysfunction.

Keywords

coxsackie B virus - hydrops - myocarditis - cerebritis - ventriculitis

• References

• 1 Moore M, Kaplan MH, McPhee J, Bregman DJ, Klein SW. Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep 1984; 99 (5) 515-522
• 2 Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 1983; 5 (6) 1019-1032
• 3 Romero JR. Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol 2008; 323 (3) 223-239
• 4 Sawyer MH. Enterovirus infections: diagnosis and treatment. Curr Opin Pediatr 2001; 13 (1) 65-69
• 5 Theodoridou M, Kakourou T, Laina I, Mostrou G, Tsakris A. Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection. Eur J Pediatr 2002; 161 (7) 412-413
• 6 Bryant PA, Tingay D, Dargaville PA, Starr M, Curtis N. Neonatal coxsackie B virus infection-a treatable disease?. Eur J Pediatr 2004; 163 (4-5) 223-228
• 7 Callen J, Paes BA. A case report of a premature infant with coxsackie B1 meningitis. Adv Neonatal Care 2007; 7 (5) 238-247
• 8 Cheng LL, Ng PC, Chan PK, Wong HL, Cheng FW, Tang JW. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 2006; 118 (3) e929-e933
• 9 Konstantinidou A, Anninos H, Spanakis N , et al. Transplacental infection of Coxsackievirus B3 pathological findings in the fetus. J Med Virol 2007; 79 (6) 754-757
• 10 Freund MW, Kleinveld G, Krediet TG, van Loon AM, Verboon-Maciolek MA. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed 2010; 95 (3) F206-F212
• 11 Bauer S, Gottesman G, Sirota L, Litmanovitz I, Ashkenazi S, Levi I. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr 2002; 161 (9) 491-493
• 12 Ouellet A, Sherlock R, Toye B, Fung KF. Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth. Infect Dis Obstet Gynecol 2004; 12 (1) 23-26
• 13 Erickson LS, Hoyle G, Abramson J, Hester LC, Shetty AK. Coxsackie B1 infection associated with ventriculitis. Pediatr Infect Dis J 2003; 22 (8) 750-751
• 14 Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995; 38 (11) 1371-1373
• 15 Tracy S, Gauntt C. Group B coxsackievirus virulence. Curr Top Microbiol Immunol 2008; 323: 49-63
• 16 Euscher E, Davis J, Holzman I, Nuovo GJ. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol 2001; 98 (6) 1019-1026
• 17 Watson WJ, Awadallah S, Jaqua MJ. Intrauterine infection with coxsackievirus: is it a cause of congenital cardiac malformations?. Infect Dis Obstet Gynecol 1995; 3 (2) 79-81
• 18 Gauntt CJ, Gudvangen RJ, Brans YW, Marlin AE. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system. Pediatrics 1985; 76 (1) 64-68
• 19 Kamei S, Hersch SM, Kurata T, Takei Y. Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue. Acta Neuropathol 1990; 80 (2) 216-221
• 20 Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 2003; 163 (4) 1379-1393
• 21 Feuer R, Whitton JL. Preferential coxsackievirus replication in proliferating/activated cells: implications for virus tropism, persistence, and pathogenesis. Curr Top Microbiol Immunol 2008; 323: 149-173
• 22 Freimuth P, Philipson L, Carson SD. The coxsackievirus and adenovirus receptor. Curr Top Microbiol Immunol 2008; 323: 67-87
• 23 Honda T, Saitoh H, Masuko M , et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000; 77 (1) 19-28
• 24 Benirschke K, Kibrick S. Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with coxsackle virus group B, type 3. N Engl J Med 1956; 255 (19) 883-889
• 25 Estes ML, Rorke LB. Liquefactive necrosis in Coxsackie B encephalitis. Arch Pathol Lab Med 1986; 110 (11) 1090-1092
• 26 Cree BC, Bernardini GL, Hays AP, Lowe G. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 2003; 60 (1) 107-112
• 27 Strong BS, Young SA. Intrauterine coxsackie virus, group B type 1, infection: viral cultivation from amniotic fluid in the third trimester. Am J Perinatol 1995; 12 (2) 78-79
• 28 Batcup G, Holt P, Hambling MH, Gerlis LM, Glass MR. Placental and fetal pathology in Coxsackie virus A9 infection: a case report. Histopathology 1985; 9 (11) 1227-1235